Pharmafile Logo
Pharmafocus logo
Advanced Search

iOnctura announces publication of pioneering research describing the unique biological features of roginolisib

March 16, 2023
Business Services

Geneva, Switzerland and Amsterdam, The Netherlands, 16 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …

News
Press release

Great Ormand Street Hospital enters commercial agreement with Leucid Bio

March 16, 2023
Medical Communications

Leucid Bio and Great Ormand Street Hospital NHS Foundation Trust (GOSH) have entered a commercial agreement to manufacture Leucid’s lead …

News

The Association of the British Pharmaceutical Industry suspends Novo Nordisk for two years

March 16, 2023
Sales and Marketing

The Association of the British Pharmaceutical Industry (ABPI) has suspended Danish pharmaceutical company Novo Nordisk after “serious breaches” of the …

News

Seamless Therapeutics launches with $12.5m in financing

March 16, 2023
Research and Development

Seamless Therapeutics, a biotech focusing on the therapeutic potential of gene therapies, has announced it received $12.5m (€11.8m) in seed …

News

Bristol Myers Squibb works with SpaceX to study biomanufacturing in space

March 16, 2023
Medical Communications

It was announced last week that the SpaceX Dragon spacecraft will make its journey to the International Space Station (ISS) …

News

PHARMANOVIA ENTERS INTO AN EXCLUSIVE LICENSING AGREEMENT WITH AETERNA ZENTARIS FOR THE FIRST AND ONLY ORALLY ADMINISTERED APPROVED MEDICINE FOR THE DIAGNOSIS OF GROWTH HORMONE DEFICIENCY IN ADULTS

March 16, 2023
Business Services

BASILDON, UK, 16 MARCH 2023 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the …

News
Press release

Zolgensma®▼ (onasemnogene abeparvovec) receives NICE final draft guidance in presymptomatic babies up to 12 months with spinal muscular atrophy (SMA)

March 16, 2023
Business Services

 London, UK, 16th March 2023 – Novartis Gene Therapies has confirmed that the National Institute for Health and Care Excellence …

News
Press release

Aldena Therapeutics Accelerates its Novel and Disruptive Approach to Immuno-Dermatology

March 16, 2023
Business Services

Boston, Massachusetts, March 16th, 2023 – Aldena Therapeutics Inc. (Aldena) a private biotech company pioneering siRNA-based therapies for dermatological indications, …

News
Press release

Cough medicines containing pholcodine withdrawn across UK

March 15, 2023
Medical Communications

Some cough syrups being sold behind the counter at pharmacies are being withdrawn due to safety concerns surrounding potential allergies …

News

Novo Nordisk to cut insulin prices by up to 75% in 2024

March 15, 2023
Sales and Marketing

Danish pharmaceutical company Novo Nordisk has announced that it will cut its prices for insulin products by up to 75%, …

News

FDA amends EUA of Pfizer-BioNTech COVID-19 vaccine for paediatric use

March 15, 2023
Medical Communications

Yesterday, the FDA announced that it has amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech bivalent COVID-19 Vaccine. The …

News

BlueRock Therapeutics collaboration over Parkinson’s disease digital health technology

March 15, 2023
Medical Communications

Clinical stage biopharmaceutical company BlueRock Therapeutics has announced a collaboration with Rune Labs and Emerald Innovations. It will look at …

News

Optibrium and PostEra Collaborate to Integrate AI Drug Discovery Solutions

March 15, 2023
Business Services

 

News
Press release

DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine

March 15, 2023
Business Services

Turku, Finland – March 15, 2023 – DelSiTech Ltd, a Finnish drug delivery and drug development company, today announces that …

News
Press release

HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China

March 14, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Tuesday, March 14, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces that, further …

News
Press release

Synaffix Announces Expansion of ADC Collaboration with MacroGenics

March 14, 2023
Business Services

AMSTERDAM, NETHERLANDS, 14 March 2023, Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the …

News
Press release

Acesion Pharma announces positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint achieved

March 14, 2023
Business Services

14 March 2023, Copenhagen, Denmark – Acesion Pharma (“Acesion”), the biotech pioneering first-in-class novel therapies for Atrial Fibrillation (“AF”), the …

News
Press release

EP0042 receives Orphan Drug Designation from the US Food and Drug Administration

March 14, 2023
Business Services

 Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …

News
Press release

Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

March 14, 2023
Business Services

Aarhus, Denmark March 14th, 2023: Teitur Trophics (“Teitur”), a biotech company dedicated to developing new treatments for patients suffering from …

News
Press release

Newron announces 2022 financial results and provides outlook for 2023

March 14, 2023
Business Services

Milan, Italy, March 14, 2023, 7 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025